BICB (BioCube) EBIT: $-0.46 Mil (TTM As of Jul. 2013)

What is BioCube EBIT?

BioCube BICB -99.00% EBIT is $-0.46 Mil as of Jul. 2013.

BioCube's earnings before interest and taxes (EBIT) for the three months ended in Jul. 2013 was $-0.09 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jul. 2013 was $-0.46 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BioCube's annualized ROC % for the quarter that ended in Jul. 2013 was -14.68%. BioCube's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2013 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

BioCube (OTCPK:BICB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BioCube's annualized ROC % for the quarter that ended in Jul. 2013 is calculated as:

	ROC % (Q: Jul. 2013 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Apr. 2013 )	+	Invested Capital (Q: Jul. 2013 ))	/ count )
=	-0.2 * ( 1 - 0% )	/	( (1.335	+	1.39)	/ 2 )
=	-0.2	/	1.3625
=	-14.68 %

where

	Invested Capital		(Q: Apr. 2013 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0.143	-	( 0	-	max(0, 1.478	-	0	+	0	))
=	1.335

	Invested Capital		(Q: Jul. 2013 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0.174	-	( 0	-	max(0, 1.564	-	0	+	0	))
=	1.39

Note: The Operating Income data used here is four times the quarterly (Jul. 2013) data.

2. Joel Greenblatt's definition of Return on Capital:

BioCube's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jul. 2013 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jul. 2013 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Apr. 2013		Q: Jul. 2013
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.368	/	( ( (0 + max(-0.454, 0))	+	(0 + max(-0.531, 0)) )	/	1 )
=	-0.368	/	( ( 0	+	0 )	/	1 )
=	-0.368	/	0
=	%

where Working Capital is:

	Working Capital		(Q: Apr. 2013 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.143	+	0	+	0.311)
=	-0.454

	Working Capital		(Q: Jul. 2013 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.174	+	0	+	0.357)
=	-0.531

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jul. 2013) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BioCube's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jul. 2013 )
	=	-0.455	/	0.000
	=	%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCube EBIT Related Terms

BioCube EBIT Historical Data

* Premium members only.

The historical data trend for BioCube's EBIT can be seen below:

BioCube EBIT Chart

BioCube Annual Data

Trend

Jun06

Jun07

Jan08

Jan09

Jan11

Jan12

Jan13

EBIT

Get a 7-Day Free Trial

-5.12

-3.08

-1.01

-0.06

-0.41

BioCube Quarterly Data
	Apr08	Jul08	Oct08	Jan09	Apr09	Oct09	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13
EBIT	Get a 7-Day Free Trial															-0.01	-0.27	-0.05	-0.05	-0.09

BICB vs MBVXQ, GWSN, CTBOD: EBIT Comparison

For the Shell Companies subindustry, BioCube's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioCube EV-to-EBIT vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BioCube's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BioCube's EV-to-EBIT falls into.

Save Embed

BioCube EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jul. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.46 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of $-0.46 Mil mean?

BioCube (BICB) has a EBIT of $-0.46 Mil as of Jul. 2013. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BioCube.

Is BioCube's EBIT too high?

BioCube's current EBIT is $-0.46 Mil.

How does BioCube's EBIT compare to MBVXQ and GWSN?

BioCube's EBIT of $-0.46 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Diversified Financial Services company?

A good EBIT depends on the Diversified Financial Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BioCube. BioCube's current EBIT is $-0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BioCube stock overvalued right now?

BioCube (BICB) has a current EBIT of $-0.46 Mil. The current EBIT is $-0.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For BioCube (BICB), the current EBIT is $-0.46 Mil as of Jul. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioCube Business Description

Industry Financial Services Diversified Financial Services

Comparable Companies MBVXQ GWSN BOM:524604 WAR:PFM CTBOD HSTC XSAT:EURI B SOAN GOVX ARGSQ PRTX PTEO BOM:506365 ATMS BOM:524796 TSXV:PBS DTHR BOM:532871 AKAOQ CAPS

Address 3060 West 3680 South, Suite 92, West Valley, UT, USA, 84119

Website http://www.biocubeinc.com

BioCube Inc is a shell company.